Even Better Clinical Acne Solutions

Description

CLINIQUE Acne Solutions Liquid Makeup is a salicylic acid acne treatment formulated to address acne-prone skin. This product is presented in a liquid dosage form, with a total volume of 1 fluid ounce (30 mL).

Uses and Indications

This drug is indicated for the management of acne. It effectively treats existing acne, clears acne blemishes, and helps prevent the development of new acne blemishes.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to ensure that the skin is thoroughly cleansed prior to the application of the medication. The recommended application frequency is once daily. However, in cases where bothersome dryness or peeling occurs, it is advisable to reduce the application frequency to every other day. This adjustment helps to mitigate adverse effects while maintaining therapeutic efficacy.

Contraindications

The use of this product is contraindicated in patients who are concurrently using another topical acne medication, as this may increase the risk of skin irritation and dryness. No other contraindications have been identified.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid concurrent use of this product with other topical acne medications, as this may increase the likelihood of skin irritation and dryness. It is recommended that patients use only one topical acne medication at a time to minimize these risks.

This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Side Effects

Patients using this product may experience skin irritation and dryness, particularly if they concurrently use another topical acne medication. To minimize the risk of these adverse reactions, it is advised that patients use only one topical acne medication at a time.

This product is intended for external use only. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate these effects, it is advised to limit the use to one topical acne medication at a time. This approach helps to minimize the potential for adverse skin reactions while ensuring the efficacy of the treatment. Monitoring for signs of irritation or dryness is recommended, and if such symptoms occur, discontinuation of one of the topical agents should be considered.

Packaging & NDC

Below are the non-prescription pack sizes of Even Better Clinical Acne Solutions (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information available regarding the use of EVEN BETTER CLINICAL ACNE SOLUTIONS (salicylic acid liquid) during pregnancy. As such, the safety of this product in pregnant patients has not been established. Healthcare professionals should exercise caution when prescribing this medication to women of childbearing potential. Given the lack of data on potential fetal impacts, it is advisable to weigh the benefits against any potential risks before recommending this treatment to pregnant patients. Further studies may be necessary to clarify the safety profile of salicylic acid in this population.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of data necessitates careful evaluation of potential risks and benefits.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Advise patients to keep this product out of reach of children. Instruct them that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Inform patients that when using this product, the likelihood of skin irritation and dryness may increase if they are using another topical acne medication concurrently. If they experience such irritation, they should be advised to use only one topical acne medication at a time to minimize the risk of adverse effects.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically and is intended for external use only. Clinicians should advise patients that the likelihood of skin irritation and dryness increases when used concurrently with other topical acne medications; therefore, it is recommended to use only one topical acne treatment at a time. Patients should be instructed to keep the product out of reach of children and to seek medical assistance or contact a Poison Control Center immediately if swallowed. In cases of bothersome dryness or peeling, patients may reduce the frequency of application to every other day.

Drug Information (PDF)

This file contains official product information for Even Better Clinical Acne Solutions, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)